United Therapeutics UTHR Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by United Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: United Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about United Therapeutics's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is United Therapeutics's other income (expense)?
- United Therapeutics (UTHR) reported other income (expense) of -$7.5M in Q1 2026.
- How has United Therapeutics's other income (expense) changed year-over-year?
- United Therapeutics's other income (expense) decreased by 118.4% year-over-year, from $40.7M to -$7.5M.
- What is the long-term trend for United Therapeutics's other income (expense)?
- Over 2 years (2023 to 2025), United Therapeutics's other income (expense) has grown at a 57.4% compound annual growth rate (CAGR), from $89.4M to $221.4M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.